Anti-MIGA2 monoclonal antibody

Pre-made anti-MIGA2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MIGA2/MIGA2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2598-Ab-1/ GM-Tg-hg-IP2598-Ab-2Anti-Human MIGA2 monoclonal antibodyHuman
GM-Tg-rg-IP2598-Ab-1/ GM-Tg-rg-IP2598-Ab-2Anti-Rat MIGA2 monoclonal antibodyRat
GM-Tg-mg-IP2598-Ab-1/ GM-Tg-mg-IP2598-Ab-2Anti-Mouse MIGA2 monoclonal antibodyMouse
GM-Tg-cynog-IP2598-Ab-1/ GM-Tg-cynog-IP2598-Ab-2Anti-Cynomolgus/ Rhesus macaque MIGA2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2598-Ab-1/ GM-Tg-felg-IP2598-Ab-2Anti-Feline MIGA2 monoclonal antibodyFeline
GM-Tg-cang-IP2598-Ab-1/ GM-Tg-cang-IP2598-Ab-2Anti-Canine MIGA2 monoclonal antibodyCanine
GM-Tg-bovg-IP2598-Ab-1/ GM-Tg-bovg-IP2598-Ab-2Anti-Bovine MIGA2 monoclonal antibodyBovine
GM-Tg-equg-IP2598-Ab-1/ GM-Tg-equg-IP2598-Ab-2Anti-Equine MIGA2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2598-Ab-1/ GM-Tg-hg-IP2598-Ab-2; GM-Tg-rg-IP2598-Ab-1/ GM-Tg-rg-IP2598-Ab-2;
GM-Tg-mg-IP2598-Ab-1/ GM-Tg-mg-IP2598-Ab-2; GM-Tg-cynog-IP2598-Ab-1/ GM-Tg-cynog-IP2598-Ab-2;
GM-Tg-felg-IP2598-Ab-1/ GM-Tg-felg-IP2598-Ab-2; GM-Tg-cang-IP2598-Ab-1/ GM-Tg-cang-IP2598-Ab-2;
GM-Tg-bovg-IP2598-Ab-1/ GM-Tg-bovg-IP2598-Ab-2; GM-Tg-equg-IP2598-Ab-1/ GM-Tg-equg-IP2598-Ab-2
Products NameAnti-MIGA2 monoclonal antibody
Formatmab
Target NameMIGA2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MIGA2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2598-Ag-1Recombinant multi-species MIGA2/ C9orf54/ FAM73B protein
    ORF Viral VectorpGMLV000333human MIGA2 Lentivirus plasmid
    ORF Viral VectorvGMLV000333human MIGA2 Lentivirus particle


    Target information

    Target IDGM-IP2598
    Target NameMIGA2
    Gene ID84895,108958,296623,722577,491305,101083979,535315,100070092
    Gene Symbol and Synonyms5730472N09Rik,C9orf54,FAM73B,MIGA2,RGD1310887
    Uniprot AccessionQ7L4E1,Q1JPG0
    Uniprot Entry NameMIGA2_HUMAN,MIGA2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000148343
    Target ClassificationN/A

    The target: MIGA2, gene name: MIGA2, also named as C9orf54, FAM73B. Enables protein heterodimerization activity and protein homodimerization activity. Involved in mitochondrial fusion. Is integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.